These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 11948488)

  • 1. Bcl-X(L) is a chemoresistance factor in human melanoma cells that can be inhibited by antisense therapy.
    Heere-Ress E; Thallinger C; Lucas T; Schlagbauer-Wadl H; Wacheck V; Monia BP; Wolff K; Pehamberger H; Jansen B
    Int J Cancer; 2002 May; 99(1):29-34. PubMed ID: 11948488
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mcl-1 antisense therapy chemosensitizes human melanoma in a SCID mouse xenotransplantation model.
    Thallinger C; Wolschek MF; Wacheck V; Maierhofer H; Günsberg P; Polterauer P; Pehamberger H; Monia BP; Selzer E; Wolff K; Jansen B
    J Invest Dermatol; 2003 Jun; 120(6):1081-6. PubMed ID: 12787138
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bcl-x(L) antisense oligonucleotides radiosensitise colon cancer cells.
    Wacheck V; Selzer E; Günsberg P; Lucas T; Meyer H; Thallinger C; Monia BP; Jansen B
    Br J Cancer; 2003 Oct; 89(7):1352-7. PubMed ID: 14520471
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activity of a novel bcl-2/bcl-xL-bispecific antisense oligonucleotide against tumors of diverse histologic origins.
    Gautschi O; Tschopp S; Olie RA; Leech SH; Simões-Wüst AP; Ziegler A; Baumann B; Odermatt B; Hall J; Stahel RA; Zangemeister-Wittke U
    J Natl Cancer Inst; 2001 Mar; 93(6):463-71. PubMed ID: 11259472
    [TBL] [Abstract][Full Text] [Related]  

  • 5. p53-Independent induction of apoptosis in human melanoma cells by a bcl-2/bcl-xL bispecific antisense oligonucleotide.
    Strasberg Rieber M; Zangemeister-Wittke U; Rieber M
    Clin Cancer Res; 2001 May; 7(5):1446-51. PubMed ID: 11350916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bcl-x(L) antisense oligonucleotides induce apoptosis and increase sensitivity of pancreatic cancer cells to gemcitabine.
    Xu Z; Friess H; Solioz M; Aebi S; Korc M; Kleeff J; Büchler MW
    Int J Cancer; 2001 Oct; 94(2):268-74. PubMed ID: 11668508
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bcl-2 family proteins and cytoskeleton changes involved in DM-1 cytotoxic effect on melanoma cells.
    Faião-Flores F; Suarez JA; Soto-Cerrato V; Espona-Fiedler M; Pérez-Tomás R; Maria DA
    Tumour Biol; 2013 Apr; 34(2):1235-43. PubMed ID: 23341182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative Bcl-2 independence of drug-induced cytotoxicity and resistance in 518A2 melanoma cells.
    Benimetskaya L; Lai JC; Khvorova A; Wu S; Hua E; Miller P; Zhang LM; Stein CA
    Clin Cancer Res; 2004 Dec; 10(24):8371-9. PubMed ID: 15623615
    [TBL] [Abstract][Full Text] [Related]  

  • 9. bcl-2 antisense therapy chemosensitizes human melanoma in SCID mice.
    Jansen B; Schlagbauer-Wadl H; Brown BD; Bryan RN; van Elsas A; Müller M; Wolff K; Eichler HG; Pehamberger H
    Nat Med; 1998 Feb; 4(2):232-4. PubMed ID: 9461199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bcl-2 and bcl-xL antisense oligonucleotides induce apoptosis in melanoma cells of different clinical stages.
    Olie RA; Hafner C; Küttel R; Sigrist B; Willers J; Dummer R; Hall J; Stahel RA; Zangemeister-Wittke U
    J Invest Dermatol; 2002 Mar; 118(3):505-12. PubMed ID: 11874491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Small inhibitor of Bcl-2, HA14-1, selectively enhanced the apoptotic effect of cisplatin by modulating Bcl-2 family members in MDA-MB-231 breast cancer cells.
    Arisan ED; Kutuk O; Tezil T; Bodur C; Telci D; Basaga H
    Breast Cancer Res Treat; 2010 Jan; 119(2):271-81. PubMed ID: 19238538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Resistance to chemotherapy-induced apoptosis via decreased caspase-3 activity and overexpression of antiapoptotic proteins in ovarian cancer.
    Yang X; Zheng F; Xing H; Gao Q; Wei W; Lu Y; Wang S; Zhou J; Hu W; Ma D
    J Cancer Res Clin Oncol; 2004 Jul; 130(7):423-8. PubMed ID: 15156398
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bcl-xL antisense oligonucleotides chemosensitize human glioblastoma cells.
    Guensberg P; Wacheck V; Lucas T; Monia B; Pehamberger H; Eichler HG; Jansen B
    Chemotherapy; 2002 Sep; 48(4):189-95. PubMed ID: 12218266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ectopic expression of Bcl-XL or Ku70 protects human colon cancer cells (SW480) against curcumin-induced apoptosis while their down-regulation potentiates it.
    Rashmi R; Kumar S; Karunagaran D
    Carcinogenesis; 2004 Oct; 25(10):1867-77. PubMed ID: 15205359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electroporation increases antitumoral efficacy of the bcl-2 antisense G3139 and chemotherapy in a human melanoma xenograft.
    Spugnini EP; Biroccio A; De Mori R; Scarsella M; D'Angelo C; Baldi A; Leonetti C
    J Transl Med; 2011 Jul; 9():125. PubMed ID: 21798045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antitumor efficacy of bcl-2 and c-myc antisense oligonucleotides in combination with cisplatin in human melanoma xenografts: relevance of the administration sequence.
    Zupi G; Scarsella M; Semple SC; Mottolese M; Natali PG; Leonetti C
    Clin Cancer Res; 2005 Mar; 11(5):1990-8. PubMed ID: 15756025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human melanoma cell lines selected in vitro displaying various levels of drug resistance against cisplatin, fotemustine, vindesine or etoposide: modulation of proto-oncogene expression.
    Kern MA; Helmbach H; Artuc M; Karmann D; Jurgovsky K; Schadendorf D
    Anticancer Res; 1997; 17(6D):4359-70. PubMed ID: 9494534
    [TBL] [Abstract][Full Text] [Related]  

  • 18. c-Myc down-regulation increases susceptibility to cisplatin through reactive oxygen species-mediated apoptosis in M14 human melanoma cells.
    Biroccio A; Benassi B; Amodei S; Gabellini C; Del Bufalo D; Zupi G
    Mol Pharmacol; 2001 Jul; 60(1):174-82. PubMed ID: 11408612
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bcl-xL is expressed in ovarian carcinoma and modulates chemotherapy-induced apoptosis.
    Liu JR; Fletcher B; Page C; Hu C; Nunez G; Baker V
    Gynecol Oncol; 1998 Sep; 70(3):398-403. PubMed ID: 9790794
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Induction of apoptosis and enhancement of chemosensitivity in human prostate cancer LNCaP cells using bispecific antisense oligonucleotide targeting Bcl-2 and Bcl-xL genes.
    Yamanaka K; Rocchi P; Miyake H; Fazli L; So A; Zangemeister-Wittke U; Gleave ME
    BJU Int; 2006 Jun; 97(6):1300-8. PubMed ID: 16686729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.